Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...
Tufts University and the Good Food Institute are salvaging cell lines from failed startups to accelerate scalable cultivated ...
The Tufts University Center for Cellular Agriculture (TUCCA), which seeks to enable production of meat, milk, and eggs from ...
Rumors indicate that Tesla might start in-house production of LFP cells in Nevada using equipment and technology from CATL. A new report about a lithium carbonate supply deal seems to confirm this ...
This article is based on a poster originally authored by Julia Scherzinger, Daniel Türk, and Fernando Aprile-Garcia from CYTENA GmbH. There is constant pressure to reduce timelines in mammalian cell ...
CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback